Zobrazeno 1 - 10
of 46
pro vyhledávání: '"George Koutsodontis"'
Autor:
Panagiota Economopoulou, George Koutsodontis, Margaritis Avgeris, Areti Strati, Christos Kroupis, Ioannis Pateras, Euthymios Kirodimos, Evangelos Giotakis, Ioannis Kotsantis, Pavlos Maragoudakis, Vassilis Gorgoulis, Andreas Scorilas, Evi Lianidou, Amanda Psyrri
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0215984 (2019)
ObjectivesHuman papillomavirus-related oropharyngeal squamous cell carcinoma (HPV+ OPSCC) is increasing in incidence. Although HPV+ OPSCC has favorable prognosis, 10 to 25% of HPV+ OPSCCs eventually recur. We sought to evaluate the feasibility of det
Externí odkaz:
https://doaj.org/article/4ef5f215057d42809d43f2bbcd7742bd
Autor:
Smaragda Kamakari, Vassiliki Kokkinou, George Koutsodontis, Polixeni Stamatiou, Christoforos Giatzakis, Anastasios Anastasakis, Ioannis Minas Aslanides, Stavrenia Koukoula, Theoni Panagiotoglou, Ioannis Datseris, Miltiadis K. Tsilimbaris
Publikováno v:
Journal of Ophthalmology, Vol 2018 (2018)
Externí odkaz:
https://doaj.org/article/093c07b15bc245f89a7efe09896e3420
Autor:
Anna-Lena Bohnen, Klaus Pantel, Galatea Kallergi, Tobias M. Gorges, Vasilis Georgoulias, Andra Kuske, Evi Lianidou, Sabine Riethdorf, Nikiforita Poulakaki, Martha Zavridou, Eleni Politaki, Dimitris Mavroudis, Amanda Psyrri, George Koutsodontis, Areti Strati, E. Kontopodis, Claudia Koch, Simon A. Joosse, Volkmar Mueller
Publikováno v:
Clinical Chemistry. 67:1395-1405
Background Circulating tumor cell (CTC) analysis is highly promising for liquid biopsy-based molecular diagnostics. We undertook a comprehensive molecular analysis of in vivo isolated CTCs in breast cancer (BrCa). Methods In vivo isolated CTCs from 4
Autor:
Christos Perisanidis, Nikolaos Papadimitriou, Maria Gkotzamanidou, Elena Vagia, Areti Strati, Evi Lianidou, George Kavourakis, Pavlos Maragoudakis, Panagiota Economopoulou, Eleni Gagari, Efthymios Kirodimos, Maria Anastasiou, Amanda Psyrri, Constantine Prikas, Ioannis Kotsantis, Evangelos Giotakis, George Koutsodontis
Publikováno v:
Oral Oncology. 94:93-100
Objectives Chemoradiation can induce immunogenic (ICD) or tolerogenic cell death. ICD relies on the generation of damage-associated molecular patterns which can stimulate toll-like receptors (TLRs). We sought to determine whether we can predict respo
Autor:
Clarence T. Sasaki, Dimitra Rontogianni, Florentia Fostira, Panagiota Economopoulou, Amanda Psyrri, Christos Perisanidis, Elena Vagia, Ioannis Kotsantis, George Koutsodontis
Publikováno v:
JCO Precision Oncology. :1-8
Autor:
Sophia Mastoraki, Evi Lianidou, Apostolos Klinakis, Martha Zavridou, George Koutsodontis, Amanda Psyrri, Areti Strati
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
We directly compared two different approaches used for Circulating Tumor Cell (CTC) isolation, a size-dependent microfluidic system versus an EpCAM-dependent positive selection for downstream molecular characterization of CTC both at the gene express
Autor:
Ahmad Awada, Jan B. Vermorken, J. R. Germà-Lluch, Ioannis S. Pateras, Amanda Psyrri, M. Degardin, Christos Kroupis, Catherine Fortpied, Margaritis Avgeris, Heinz Roland Kienzer, Jessica Menis, George Koutsodontis, L. Herman, Nikolaos Goutas, Lisa Licitra, Johannes A. Langendijk, Livia Giurgea, Éva Remenár, C.M.L. van Herpen
Publikováno v:
Annals of Oncology, 28, 2213-2218
Annals of Oncology, 28(9), 2213-2218. Oxford University Press
Annals of Oncology, 28, 9, pp. 2213-2218
Annals of oncology
Annals of oncology, 28 (9
Annals of Oncology, 28(9), 2213-2218. Oxford University Press
Annals of Oncology, 28, 9, pp. 2213-2218
Annals of oncology
Annals of oncology, 28 (9
Background: EORTC 24971 was a phase III trial demonstrating superiority of induction regimen TPF (docetaxel, cisplatin, 5-fluorouracil) over PF (cisplatin/5-fluorouracil), in terms of progression-free (PFS) and overall survival (OS) in locoregionally
Autor:
Christos Perisanidis, Amanda Psyrri, Panagiota Economopoulou, Martine Mazel, Catherine Alix-Panabières, Evi Lianidou, Clarence T. Sasaki, Georgios Papaxoinis, Martha Zavridou, Margaritis Avgeris, Areti Strati, George Koutsodontis, Ioannis Kotsantis, Ilias Angelidis
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2017, 28 (8), pp.1923--1933. ⟨10.1093/annonc/mdx206⟩
Annals of Oncology, Elsevier, 2017, 28 (8), pp.1923--1933. ⟨10.1093/annonc/mdx206⟩
International audience; Background: Successful application of programmed death 1 (PD1) checkpoint inhibitors in the clinic may ultimately benefit from appropriate patient selection based upon predictive biomarkers. Molecular characterization of circu
Autor:
Christos Valavanis, Natasa Novkovic, Mary Petraki, Helen Trihia, Elias Efstathiou, George Koutsodontis
Publikováno v:
The breast journalREFERENCE. 26(2)
Autor:
Ioannis S. Pateras, Pavlos Maragoudakis, Areti Strati, Euthymios Kirodimos, Margaritis Avgeris, Panagiota Economopoulou, Amanda Psyrri, Ioannis Kotsantis, Evi Lianidou, Andreas Scorilas, Vassilis G. Gorgoulis, Christos Kroupis, George Koutsodontis, Evangelos Giotakis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 5, p e0215984 (2019)
PLoS ONE, Vol 14, Iss 5, p e0215984 (2019)
ObjectivesHuman papillomavirus-related oropharyngeal squamous cell carcinoma (HPV+ OPSCC) is increasing in incidence. Although HPV+ OPSCC has favorable prognosis, 10 to 25% of HPV+ OPSCCs eventually recur. We sought to evaluate the feasibility of det